Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Jo Holmes"'
Using detailed case studies, this book focuses on the needs of children with a range of behavioural difficulties, and explores their complicated interactions. The book examines how to integrate multi-disciplinary interventions and how to use the powe
Publikováno v:
BMJ Open Respiratory Research, Vol 6, Iss 1 (2019)
Introduction People with severe asthma experience unpredictable daily symptoms requiring an intense treatment regimen impacting on health-related quality of life (QoL). Sexuality contributes to this, yet there is a dearth of research exploring intima
Externí odkaz:
https://doaj.org/article/b68d5226ed91416d8d58ea1e1a31dadd
Publikováno v:
Airway pharmacology and treatment.
Autor:
James Wingfield-Derby, Leanne Jo Holmes, Thomas Pantin, L Elsey, Lorna Maguire, Kate Newman, Stephen J. Fowler
Publikováno v:
Airway pharmacology and treatment.
Introduction: Mepolizumab is an anti-IL-5 monoclonal antibody indicated for the treatment of severe asthma. We have evaluated patient outcomes over the first 18-months of treatment, and investigated comorbidities in non-responders. Method: Data from
Publikováno v:
Monitoring airway disease.
Introduction: Adherence to maintenance inhaled therapy and correct inhaler technique are essential for good asthma control. In our adult severe asthma new patient multidisciplinary assessment a pharmacy-led medication review confirms adherence to pre
Publikováno v:
Airway pharmacology and treatment.
Background: Manchester severe asthma team have treated 243 patients to date with Mepolizumab since it became available in the UK for the treatment of severe eosinophilic asthma in April 2017. Patients are weaned off their maintenance steroids followi
Publikováno v:
Monitoring airway disease.
Introduction: Cause of death and morbidity in severe asthma patients has not been studied since 2014 (1). Oral corticosteroid (OCS) burden should be considered in the context of biological therapy licensing for severe eosinophilic asthma. Aims: To un
Autor:
Anne-Marie Doyle, Andrew Menzies-Gow, Janelle Yorke, Pauline Adair, Leanne Jo Holmes, Linda Dubrow-Marshall, Robert Niven, Caroline Shuldham, Mark Pilling, Sharon Fleming
Publikováno v:
Yorke, J, Adair, P, Doyle, A-M, Dubrow-Marshall, L, Fleming, S L, Holmes, L, Menzies-Gow, A, Niven, R, Pilling, M & Shuldham, C 2017, ' A randomised controlled feasibility trial of Group Cognitive Behavioural Therapy for people with severe asthma ', Journal of Asthma, vol. 54, no. 5, pp. 543-554 . https://doi.org/10.1080/02770903.2016.1229335
Yorke, J, Adair, P, Doyle, A-M, Dubrow-Marshall, L, Fleming, S, Holmes, L & Shuldham, C 2016, ' A randomised controlled feasibility trial of Group Cognitive Behavioural Therapy for people with severe asthma ', Journal of Asthma . https://doi.org/10.1080/02770903.2016.1229335
Yorke, J, Adair, P, Doyle, A-M, Dubrow-Marshall, L, Fleming, S, Holmes, L & Shuldham, C 2016, ' A randomised controlled feasibility trial of Group Cognitive Behavioural Therapy for people with severe asthma ', Journal of Asthma . https://doi.org/10.1080/02770903.2016.1229335
Objectives: Evidence for the efficacy of Cognitive Behavioural Therapy (CBT) in asthma is developing but it is not known if this translates to benefits in severe asthma or if a group approach is acceptable to this patient group. This study aimed to a
Publikováno v:
Nurses.
Publikováno v:
1.11 Clinical Problems - Asthma.
Background: Cognitive decline in EGPA is rare. 30% of patients with small vessel vasculitis may have subclinical neuropsychological impairment 1 . Data is limited regarding EGPA alone. Aim: To evaluate prevalence of cognitive impairment in patients w